American Journal of Physiology-Heart and Circulatory PhysiologyDevelopmental BiologyPeer-reviewed journal article
Osteopontin Mediates Uterine Artery Dysfunction in Hypertensive Pregnancy
Megan L LaveiD, Jordan Jones, Violet S. PattersoniD, Stella Zhizhi Li, Martin W. McBrideiD, Delyth GrahamiD, James C. LacefieldiD, Genevieve D. M. EastabrookiD, Stephen James RenaudiD
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 39th percentile
Abstract
BackgroundSuccessful pregnancy requires substantial maternal cardiovascular adaptation, including expansion and remodelling of the uterine arteries to support increased nutrient flow to the fetus. Hypertension is associated with impaired uterine artery remodelling and increased risk of fetal growth restriction and other adverse outcomes, yet the mechanisms driving vascular dysfunction in hypertensive pregnancy remain incompletely understood. Osteopontin, a matricellular protein, is implicated in vascular pathology in hypertension, positioning it as a candidate mediator of impaired uterine artery adaptation during hypertensive pregnancy. MethodsUterine artery remodelling was compared between pregnant normotensive Wistar-Kyoto (WKY) rats and spontaneously hypertensive stroke-prone rats (SHRSP), a model of chronic hypertension. To determine the role of osteopontin in this process, an osteopontin-deficient SHRSP strain was characterized. Uterine artery blood flow was assessed by Doppler ultrasound, arterial structure was evaluated by histology, and molecular differences were identified by RNA sequencing. Fetal weight and length were measured at mid and late gestation. ResultsCompared with WKY, SHRSP fetuses were smaller, and uterine arteries exhibited inward hypertrophic remodelling, characterized by increased wall thickness, reduced lumen area, and elevated resistance index. SHRSP uterine arteries also showed increased expression of inflammatory and vascular pathology-associated genes, including osteopontin. In osteopontin-deficient SHRSP, uterine arteries had larger lumen areas, decreased resistance index, and reduced expression of inflammation-associated genes. Fetal growth was also improved in osteopontin-deficient SHRSP pregnancies. ConclusionsThese findings identify osteopontin as a contributor to impaired uterine artery adaptation and suggest that reduced osteopontin may improve vascular remodelling and fetal growth in hypertensive pregnancies.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- High-salt diet disturbs the physiological uterine endothelial junction remodeling during pregnancy
Lin Huang, Shuangbo Kong, … Jingsi Chen·Life SciencesPeer-reviewed·Apr 19, 2026
- Maternal cardiometabolic dysfunction and fetal sex-specific alterations to uterine vascular reactivity in an ovine model of diet-induced obesity during pregnancy
Rachael C. Crew, A. G. COCHRANE, … Dino A. Giussani·bioRxiv·Jan 16, 2026
- Adaptations of the pregnant murine heart to pre-existing hypertension
Elnaz Ghajar-Rahimi, Arden Shen, … Craig J. Goergen·bioRxiv·Sep 16, 2026
- TNF-α-Driven NOX5 Activation Promotes Oxidative Stress and Umbilical Artery Dysfunction in Preeclampsia
Nayara Carvalho Barbosa, Mirele Resende Machado, … Rafael M Costa·bioRxiv·May 21, 2026
- Maternal adiponectin restores cholinergic vasodilation in resistance vessels from adult offspring exposed to maternal obesity in utero
Molly O. Murphy, Sahand Fallahi, … Ramón A. Lorca·bioRxiv·Sep 21, 2024
- Effect of intracerebroventricular epinephrine microinjection on blood pressure and urinary sodium handling in gestational protein-restricted rat adult male offspring
J. A. Gontijo, P. A. Boer, … B. V. Cardoso·bioRxiv·Sep 12, 2018